NENatonalinsutute forHealth and Care ExcellenceNICE贝guidancePolatuzumab vedotin incombination for untreateddiffuse large B-celllymphomaTechnology appraisal guidancePublished:1 March 2023www.nice.org.uk/guidance/ta874NICE 2023.All rights reserved.Subject to Notice of rights (https://www.nice.org.uk/temms-and-conditions#notice-of-rights).